Tissue Repair
Tissue Repair Research Peptides
Repair-model research peptides are studied in wound-healing, tendon, muscle and gastrointestinal injury models, and the mechanisms proposed for them differ considerably from one compound to the next. BPC-157 has been examined largely in relation to nitric-oxide signalling and angiogenesis; TB-500, the synthetic fragment of thymosin beta-4, is studied for actin sequestration and cell migration; GHK-Cu is a copper-binding tripeptide with a separate literature centred on collagen and matrix remodelling.
That divergence matters when reading the evidence. Much of the BPC-157 literature originates from a single research group and remains preclinical, a limitation the published reviews state directly and one worth knowing before drawing conclusions from it. The compound pages in this category summarise what has been reported and cite the primary papers rather than asserting outcomes.
Every batch is independently tested before release, and both figures are published: purity from HPLC, and measured content against the labelled amount. Certificates are linked per lot to the vial in hand. All compounds here are supplied strictly for in-vitro laboratory research.
In this category: BPC-157 · TB-500 · KPV · GHK-Cu · IGF-1 LR3
What to check before buying tissue repair compounds
Purity is half the number. A purity figure tells you what fraction of the powder in the vial is the compound on the label — it tells you nothing about how much powder is in the vial. A lot can assay at 99.8% purity and still be short against its labelled content.
Both numbers are published for every batch here: purity from HPLC, and measured mass against expected content. Match the batch code printed on the vial to the certificate before you rely on either.
Tissue Repair research peptides — common questions
- Is most of the BPC-157 research really from one research group?
- A large share of it is, and the published reviews say so directly. The body of work centred on Sikiric and colleagues accounts for much of the preclinical literature, and it remains preclinical. That is a limitation worth knowing before drawing conclusions from the volume of papers alone, and it is stated on the compound page rather than left for a reader to discover.
- What is the difference between TB-500 and thymosin beta-4?
- Thymosin beta-4 is the full 43-residue peptide. TB-500 is a synthetic fragment of it, most commonly the actin-binding region, and it is the fragment rather than the whole peptide that is supplied and studied under that name. Papers on one are not automatically papers on the other, which is why the two are cited separately on the product page.
- Why is GHK-Cu grouped with BPC-157 and TB-500?
- Because the models overlap, not because the mechanism does. GHK-Cu is a copper-binding tripeptide with its own literature around collagen and matrix remodelling; BPC-157 is studied largely in relation to nitric-oxide signalling and angiogenesis. They appear together because repair-model research draws on all three, and the compound pages keep their evidence bases separate.
- How do I confirm the vial I received matches the certificate?
- Match the lot code printed on the vial label to the lot code on the certificate. Every certificate this store publishes is tied to a lot code rather than to a product, so a certificate with no lot code on it proves nothing about any particular vial. The batch lookup on the verification page resolves a code straight to its report.
